Mega Lifesciences PCL (BKK:MEGA)

Thailand flag Thailand · Delayed Price · Currency is THB
28.25
+0.75 (2.73%)
Apr 25, 2025, 10:30 AM ICT
-31.10%
Market Cap 23.98B
Revenue (ttm) 15.39B
Net Income (ttm) 2.01B
Shares Out 871.87M
EPS (ttm) 2.31
PE Ratio 11.91
Forward PE 10.51
Dividend 1.60 (5.82%)
Ex-Dividend Date Mar 7, 2025
Volume 228,129
Average Volume 978,609
Open 27.75
Previous Close 27.50
Day's Range 27.75 - 28.25
52-Week Range 26.50 - 41.25
Beta 0.44
RSI 34.78
Earnings Date May 14, 2025

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sl... [Read more]

Sector Healthcare
Founded 1982
Employees 900
Stock Exchange Stock Exchange of Thailand
Ticker Symbol MEGA
Full Company Profile

Financial Performance

In 2024, Mega Lifesciences PCL's revenue was 15.39 billion, a decrease of -2.10% compared to the previous year's 15.72 billion. Earnings were 2.01 billion, an increase of 0.99%.

Financial Statements

News

There is no news available yet.